Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia

Exp Mol Med. 2008 Feb 29;40(1):11-8. doi: 10.3858/emm.2008.40.1.11.

Abstract

Recent studies have reported that the cholinergic anti-inflammatory pathway regulates peripheral inflammatory responses via alpha7 nicotinic acetylcholine receptors (alpha7 nAChRs) and that acetylcholine and nicotine regulate the expression of proinflammatory mediators such as TNF-alpha and prostaglandin E2 in microglial cultures. In a previous study we showed that ATP released by beta-amyloid-stimulated microglia induced reactive oxygen species (ROS) production, in a process involving the P2X(7) receptor (P2X(7)R), in an autocrine fashion. These observations led us to investigate whether stimulation by nicotine could regulate fibrillar beta amyloid peptide (1-42) (fAbeta1-42)-induced ROS production by modulating ATP efflux-mediated Ca(2+) influx through P2X(7)R. Nicotine inhibited ROS generation in fAbeta(1-42)-stimulated microglial cells, and this inhibition was blocked by mecamylamine, a non-selective nAChR antagonist, and a-bungarotoxin, a selective alpha7 nAChR antagonist. Nicotine inhibited NADPH oxidase activation and completely blocked Ca(2+) influx in fAbeta(1-42)-stimulated microglia. Moreover, ATP release from fAbeta(1-42)-stimulated microglia was significantly suppressed by nicotine treatment. In contrast, nicotine did not inhibit 2',3'-O-(4-benzoyl)-benzoyl ATP (BzATP)-induced Ca(2+) influx, but inhibited ROS generation in BzATP-stimulated microglia, indicating an inhibitory effect of nicotine on a signaling process downstream of P2X(7)R. Taken together, these results suggest that the inhibitory effect of nicotine on ROS production in fAbeta1-42-stimulated microglia is mediated by indirect blockage of ATP release and by directly altering the signaling process downstream from P2X(7)R.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / metabolism
  • Adenosine Triphosphate / pharmacology
  • Amyloid / metabolism*
  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Calcium / metabolism
  • Enzyme Activation / drug effects
  • Microglia / cytology
  • Microglia / drug effects*
  • Microglia / enzymology
  • Microglia / metabolism*
  • NADPH Oxidases / metabolism
  • Nicotine / pharmacology
  • Nicotinic Antagonists / pharmacology
  • Peptide Fragments / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism*
  • Receptors, Nicotinic / metabolism*
  • Receptors, Purinergic P2 / metabolism
  • Receptors, Purinergic P2X7

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • Nicotinic Antagonists
  • Peptide Fragments
  • Reactive Oxygen Species
  • Receptors, Nicotinic
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2X7
  • amyloid beta-protein (1-42)
  • 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate
  • Nicotine
  • Adenosine Triphosphate
  • NADPH Oxidases
  • Calcium